Matthew Holian > DLA Piper LLP (US) > Boston, United States > Lawyer Profile

Drawing upon the expertise of ‘industry leaders who take a strategic and proactive approach to managing mass tort and related product liability litigation’, DLA Piper LLP (US) is a popular choice among life sciences clients for critical and business sensitive disputes. The firm displays ‘a very collaborative process in how they approach cases’, and is able to very effectively lead major MDLs/class actions utilizing lawyers with ‘a deep understanding of the biopharmaceutical industry’, as well as core procedural prowess. The firm has secured ‘exceptional results’ for many clients regularly securing mass tort victories at an early stage through persuasive dispositive motions, including as it relates to striking out plaintiff experts through Daubert Motions. Recognized as ‘the pre-eminent leader and authority in the mass tort, product liability and life-sciences area’, New York-based partner Loren Brown  has been pivotal to many of these early successes, including his success, alongside ‘innovative thinker’ Raymond Williams , for Novo Nordisk at summary judgment in mass tort litigation involving claims that its diabetes medication Victoza causes pancreatic cancer. ‘Outstanding’ Atlanta-based product liability team head Christopher Campbell  leads from the front and is noted for his ‘excellent legal skills’ and ‘co-ordination skills’, including in the context of large-scale multinational matters. Based out of Boston, Matthew Holian co-chairs the firm’s life sciences sector and regularly forms a key member of national counsel roles the firm has in complex, multi-jurisdictional product liability suits. Also based in Boston, Katie Insogna continues to impress life sciences clients and is particularly effective developing expert witnesses, on discovery matters and in relation to dispositive motions. Other key members of the team include Lucas Przymusinski , whose ‘knowledge of science and medical aspects of a case is at the cutting edge of the industry’, and Dallas-based first-chair trial lawyer Lyn Pruitt .

The ‘top-notch, best-in-class‘ practice at DLA Piper LLP (US) handles a diverse range of mandates, including Hatch-Waxman suits, supply agreements, and drug pricing and market access matters. Matthew Holian and Andy Gilbert jointly head the practice from Boston and New Jersey, respectively. Holian assists medical device and pharmaceutical corporates with compliance investigations and defends clients against claims from patients in clinical trials, while Gilbert dispenses advice to life sciences companies on corporate financing, licensing, and M&A. In the New York office, Loren Brown, rated by clients as an ‘internationally known and respected litigator’, heads the disputes practice, frequently leading mass-tort actions for multinational life sciences companies including Pfizer, Novo Nordisk, and Honeywell. Katie Insogna works out of the Boston office, handling all matters concerning the defense of medical device and pharmaceutical companies in product liability litigations, while New York-based ‘top-tier attorney‘ Lucas Przymusinski handles drug and device litigations, product safety-issues, and recalls.